Chitosan gynecological gel and preparation method thereof

By using chitosan and traditional Chinese medicine extracts, the gynecological gels are solved, and the problems of high toxicity, strong corrosiveness and high cost are achieved, and good antibacterial and anti-inflammatory effects and biocompatibility are achieved, which is suitable for female care needs. .

CN118902983APending Publication Date: 2024-11-08SHANGHAI DONGLIDA HEALTH RES INST CO LTD
View PDF 0 Cites 3 Cited by

Patent Information

Application Number
CN202410952658.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-16
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing gynecological gels have problems of high toxicity, strong corrosiveness and high cost, especially traditional antibacterial agents such as silver ions are irritating to the vaginal mucosa and have high cost.

Method used

Chitosan is used as the main antibacterial component, combined with glycerol, sodium hyaluronate, hydroxyethyl cellulose, lactic acid and Chinese medicine extracts, to prepare a slightly acidic gynecological gel to achieve antibacterial through physical barrier and biocompatibility. Effects, and improve antibacterial function and biocompatibility by adjusting pH and alkalinity and adding β-glucan, oligoisomalose and other ingredients.

Benefits of technology

It achieves good antibacterial and anti-inflammatory effects, protects vaginal mucosa, repairs damaged tissue, regulates bacterial flora and hormone levels, improves dry problems, and reduces costs. The ingredients have no toxic side effects and are environmentally friendly.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The invention relates to the technical field of female care, in particular to chitosan gynecological gel and a preparation method thereof. The chitosan gynecological gel is prepared from the following raw materials: 0.5 to 2 percent of chitosan, 10 to 30 percent of glycerol, 0.1 to 1 percent of sodium hyaluronate, 0.01 to 0.5 percent of disodium ethylene diamine tetraacetate, 1 to 2.5 percent of hydroxyethyl cellulose, 0.5 to 1.5 percent of lactic acid, 0.001 to 0.1 percent of fructus cnidii extract, 0.001 to 0.1 percent of radix scutellariae extract, 0.001 to 0.1 percent of radix sophorae flavescentis extract, 0.001 to 0.1 percent of radix stemonae extract, 0.01 to 0.1 percent of herba leonuri extract and the balance of water. The chitosan gynecological gel disclosed by the invention has good antibacterial and anti-inflammatory effects, the used components have very good biocompatibility, meanwhile, the chitosan gynecological gel has no destructive effect on the environment and no toxic or side effect on a human body, and the problem of high antibacterial cost of traditional silver ions and the like is solved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of female care, in particular to a chitosan gynecological gel and a preparation method thereof. Background Art

[0002] Gynecological diseases are common diseases among women. Imbalance of flora, damage to mucosa, destruction of microenvironment and other reasons can all lead to the occurrence of gynecological diseases, such as Trichomonas vaginitis and bacterial vaginitis, which have a great impact on women's lives and work. In addition to relying on one's own immune system, the treatment of such gynecological diseases is usually accompanied by drug treatment. Gynecological gels, as commonly used drugs for gynecological diseases, are widely used in daily care and treatment. Traditional gynecological gels mostly use antibacterial agents such as aldehydes and acids, but these antibacterial agents are highly toxic and corrosive, and are highly irritating to the vaginal mucosa and skin. After long-term use, they are easy to damage the vaginal mucosa and destroy the pH balance, which leads to the recurrence of gynecological problems. At present, gynecological gels generally add silver ions with strong bactericidal effects, but silver ions have the problem of high cost. Summary of the invention

[0003] The invention provides a chitosan gynecological gel and a preparation method thereof, which are used to solve the problems of high toxicity, strong corrosiveness, high cost and the like of the gynecological gel in the prior art.

[0004] According to a first aspect of the present invention, the present invention provides a chitosan gynecological gel. The raw materials for preparing the chitosan gynecological gel include, by weight percentage: 0.5-2% chitosan, 10-30% glycerol, 0.1-1% sodium hyaluronate, 0.01-0.5% disodium ethylenediaminetetraacetic acid, 1-2.5% hydroxyethyl cellulose, 0.5-1.5% lactic acid, 0.001-0.1% cnidium monnieri extract, 0.001-0.1% scutellaria baicalensis extract, 0.001-0.1% sophora flavescens extract, 0.001-0.1% stemon extract, 0.01-0.1% leonurus extract, and the rest is water.

[0005] In the above scheme, the chitosan gynecological gel of the present invention includes chitosan, glycerol, sodium hyaluronate, disodium edetate, hydroxyethyl cellulose, lactic acid, Cnidium monnieri, Scutellaria baicalensis, Sophora flavescens, Stemona japonica extract, and Leonurus japonicus extract, wherein chitosan is the main antibacterial component, which is easy to form a film automatically on the surface of the material, and can physically block the invasion of microorganisms. Chitosan also has excellent biocompatibility and biodegradability. The female vagina is an acidic environment, so the prepared gynecological gel should be acidic, so that it can better play a protective role. Lactic acid is an auxiliary antibacterial component. As an acidic substance, it can consume a large amount of cell energy and affect the stability of the cell membrane; it not only solves the problem of high antibacterial costs such as traditional silver ions, but also has better biocompatibility and high safety. The role of sodium hyaluronate gel is to relieve intrauterine adhesions, increase intrauterine volume, and improve the thickness and blood supply of the endometrium. The role of disodium edetate is to assist in balancing the pH of the system and protect the skin or mucous membrane from irritation. Hydroxyethylcellulose is selected as the main gel system, which can not only maintain a certain viscosity and good transparency, but also remain stable under acidic conditions. Chitosan gynecology adds Chinese medicine extracts to achieve the functions of antibacterial and private care integration. Cnidium monnieri and Sophora flavescens can clear away heat and dampness, and are effective for private itching and eczema; Scutellaria baicalensis has antibacterial, antioxidant, freckle whitening, sunscreen, firming and anti-wrinkle, and anti-allergic effects; Stemona has antibacterial and anti-inflammatory effects, and exerts antibacterial effects together with lactic acid and chitosan; Motherwort extract has the effects of promoting blood circulation and removing blood stasis, regulating menstruation and regenerating new, dehydrating and detumescence, and can be used to treat menstrual disorders, amenorrhea, dysmenorrhea, endocrine, and maintenance of private parts. The chitosan gynecological gel of the present invention limits the amount of each component to a reasonable range value, so that the components play a better synergistic effect, can protect nerves and mucosal tissues, repair damaged tissues and promote wound healing, and can also regulate flora, regulate hormone levels, and improve the problem of vaginal dryness. The chitosan gynecological gel of the invention has good antibacterial and anti-inflammatory effects, and the used components have very good biocompatibility, and at the same time have no destructive effect on the environment, no toxic side effects on the human body, and solves the problem of high cost of traditional antibacterial agents such as silver ions.

[0006] Furthermore, the raw materials for preparing the chitosan gynecological gel also include: 0.1-0.3% β-glucan, calculated by weight percentage.

[0007] In the above scheme, β-glucan is an important natural polysaccharide with multiple biological activities and pharmacological effects. It plays an important role in immunomodulation, anti-inflammatory, anti-tumor, anti-oxidation, etc., and when applied to the chitosan gynecological gel of the present invention in a specific dosage, it can play a better synergistic effect with other antibacterial ingredients, thereby improving the antibacterial function of the chitosan gynecological gel of the present invention.

[0008] Furthermore, the raw materials for preparing the chitosan gynecological gel also include, by weight percentage: 0.01-0.1% isomaltooligosaccharide.

[0009] In the above scheme, isomaltooligosaccharide has the effect of promoting the growth of lactobacillus and inhibiting the growth of Candida albicans, and has the effect of preventing and treating candidal vaginitis. When it is applied to the chitosan gynecological gel of the present invention in a specific dosage, it can exert a better synergistic effect with other antibacterial ingredients, thereby improving the antibacterial function of the chitosan gynecological gel of the present invention.

[0010] In order to achieve better antibacterial effect, further, the raw materials for preparing the chitosan gynecological gel include, by weight percentage: chitosan 1-1.5%, β-glucan 0.1-0.2%, isomaltooligosaccharide 0.03-0.08%, glycerol 15-25%, sodium hyaluronate 0.15-0.25%, disodium edetate 0.05-0.15%, hydroxyethyl cellulose 1.5-2%, lactic acid 0.8-1.2%, Cnidium monnieri extract 0.005-0.015%, Scutellaria baicalensis extract 0.005-0.015%, Sophora flavescens extract 0.005-0.015%, Stemona japonica extract 0.005-0.015%, Leonurus japonicus extract 0.03-0.08%, and the rest is water.

[0011] Furthermore, the raw materials for preparing the chitosan gynecological gel include, by weight percentage: 1.1% chitosan, 0.1% β-glucan, 0.05% isomaltooligosaccharide, 20% glycerol, 0.2% sodium hyaluronate, 0.1% disodium ethylenediaminetetraacetic acid, 1.6% hydroxyethyl cellulose, 1% lactic acid, 0.01% cnidium monnieri extract, 0.01% scutellaria baicalensis extract, 0.01% sophora flavescens extract, 0.01% stemon extract, 0.05% leonurus extract, and the rest is water.

[0012] In order to achieve better antibacterial effect and effectively regulate pH, further, the purity of the lactic acid is ≥90%.

[0013] In order to obtain chitosan gynecological gel with suitable viscosity for easy use, the viscosity of the hydroxyethyl cellulose in a 1% aqueous solution at 20° C. is 3400-5000 cps.

[0014] Furthermore, the pH value of the chitosan gynecological gel is 3.5-4.5, preferably 3.8-4.1, and more preferably 3.85-3.95.

[0015] According to the second aspect of the present invention, the present invention also provides a method for preparing the above-mentioned chitosan gynecological gel, comprising the following steps: Step 1: Add chitosan, glycerol, sodium hyaluronate, and disodium edetate into water, and stir to mix and dissolve at room temperature; preferably, add chitosan, β-glucan, isomaltooligosaccharide, glycerol, sodium hyaluronate, and disodium edetate into water, and stir to mix and dissolve at room temperature; Step 2: Under stirring, add hydroxyethyl cellulose to the mixed solution of step 1 and stir to make the hydroxyethyl cellulose swell into a gel, and then cool to below 37°C; Step 3: Add lactic acid, Cnidium monnieri extract, Scutellaria baicalensis extract, Sophora flavescens extract, Stemona japonica extract and Leonurus japonicus extract in sequence at room temperature, stir evenly, and adjust the pH value of the product to acidic.

[0016] The preparation method of the invention is simple, easy to implement and suitable for wide application.

[0017] In order to fully dissolve each component, further, in step 2, the stirring is magnetic stirring at 75-85° C. for 20-40 min.

[0018] Furthermore, in step 3, the pH value of the product is adjusted to 3.5-4.5. It should be noted that the pH test method is: take 1.5g of sample, add 15g of purified water to dilute and stir well, and then test the pH value.

[0019] In the above scheme, by stabilizing the pH value of the chitosan gynecological gel within the range of 3.5-4.5, it can better match the environment of the female vagina and play a better protective role on the vagina.

[0020] The present invention provides a chitosan gynecological gel, the main raw materials of which are chitosan, glycerol, sodium hyaluronate, disodium ethylenediaminetetraacetic acid, hydroxyethyl cellulose, lactic acid, water, and a small amount of Chinese medicine component extract is added. At present, there are few gynecological gels on the market that use chitosan as the main antibacterial agent, and the lactic acid in the system also has a certain antibacterial effect. The present invention uses lactic acid and chitosan as the antibacterial system, and lactic acid can adjust the pH value and improve the private microecology. It does not contain traditional antibacterial agents and preservatives, and is safe and mild. At the same time, classic famous prescription extracts and motherwort extracts are added, which can inhibit bacteria and maintain the private parts at the same time.

[0021] The chitosan gynecological gel of the present invention can protect nerves and mucosal tissues, repair damaged tissues and promote wound healing, and can also regulate flora, regulate hormone levels, and improve the problem of vaginal dryness. The gynecological gel of the present invention has good antibacterial and anti-inflammatory effects, and the ingredients used have very good biocompatibility. There is no damage to the environment, and the problem of high cost of traditional antibacterial such as silver ions is solved. The method of using the chitosan gynecological gel of the present invention is: pour the chitosan gynecological gel into a booster, remove the cover of the booster when using it, and then slowly push the gel into the vagina, one course of treatment is 7 days, one (3 grams) a day, avoid using it during menstruation. DETAILED DESCRIPTION

[0022] In order to make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention is described clearly and completely below. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0023] Unless otherwise specified, all raw materials used in the following examples and comparative examples are commercially available.

[0024] Examples 1-5, Comparative Examples 1-2

[0025] Examples 1-5 and Comparative Examples 1-2 each independently provide a chitosan gynecological gel, the raw material composition of which is shown in Table 1 below in terms of weight percentage. The preparation method of the chitosan gynecological gel comprises the following steps: Step 1: Add chitosan, β-glucan, isomaltooligosaccharide, glycerol, sodium hyaluronate and disodium edetate into water, and stir to mix and dissolve at room temperature.

[0026] Step 2: While stirring, add hydroxyethyl cellulose to the mixed solution of step 1 and stir magnetically at 75-85°C for 20-40 minutes to allow the hydroxyethyl cellulose to swell into a gel, and then cool to below 37°C.

[0027] Step 3: Add lactic acid, Cnidium monnieri extract, Scutellaria baicalensis extract, Sophora flavescens extract, Stemona japonica extract and Leonurus japonicus extract in sequence at room temperature, stir evenly, and adjust the pH value of the product.

[0028] Table 1

[0029] Comparative Example 3

[0030] This comparative example provides a chitosan gynecological gel, which is different from Example 1 in that an equal amount of brown algae oligosaccharide is used to replace chitosan.

[0031] The preparation method of the chitosan gel in this comparative example is the same as that in Example 1.

[0032] Comparative Example 4

[0033] This comparative example provides a chitosan gynecological gel, which is different from Example 1 in that an equal amount of citric acid is used instead of lactic acid.

[0034] The preparation method of the chitosan gel in this comparative example is the same as that in Example 1.

[0035] Product performance testing

[0036] 1. Microbial limit detection: According to the test basis in Appendix B of the "Hygiene Standard for Disposable Sanitary Products" GB 15979-2002, the total number of colonies in the samples was tested. The results are shown in Table 2: Table 2

[0037] 2. Antibacterial experiment: The antibacterial test was conducted according to the standard of C3 of "Sanitary Standards for Disposable Hygiene Products" GB15979-2002 (Appendix C). At the test temperature of 20℃±1℃, the sample was exposed to Escherichia coli, Staphylococcus aureus, and Candida albicans for 5.0 minutes. After 3 repeated tests, the test results are as follows in Table 3: Table 3

[0038] 3. Vaginal mucosal irritation test: Test basis and conditions: "Procedures and methods for toxicological evaluation of safety of disinfectants" (GB / T 3896-2020), the samples are tested as is, the ambient temperature is 21℃~24℃, and the relative humidity is 49%~52%.

[0039] Test method: 6 New Zealand rabbits, female virgin rabbits, weighing 2.4kg-2.8kg, were randomly divided into an experimental group and a control group, with 3 rabbits in each group. 2mL of the original sample was slowly injected into the vagina through the catheter, and the animals in the control group were treated in the same way with normal saline. 24 hours after exposure, the animals were killed by CO2 anesthesia, and the vagina was removed. The naked eye was observed for congestion, edema, etc., and then fixed in 10% formalin solution for 24 hours. The tissue sections of the two ends and three central parts of the vagina were taken for pathological examination after HE staining. The stimulation response scores of the three parts of the three animals in the experimental group were added together and then divided by the total number of observations (number of animals × 3). The scoring method of the control group was the same. After the stimulation index was obtained by subtracting the average score of the experimental group from the average score of the control group, the stimulation intensity was graded.

[0040] The test results are shown in Table 4 below.

[0041] Table 4

[0042] It can be seen from the above experimental results that in all the embodiments and comparative examples, it can be seen that the chitosan gynecological gel of the present invention has good antibacterial and anti-inflammatory effects. The gynecological gels of Comparative Examples 1 and 2 have pH values ​​that are too low and too high, which will destroy the vaginal pH value when used. Too low pH values ​​will irritate the vagina, and too high pH values ​​will significantly reduce the antibacterial effect. The chitosan gynecological gels of Examples 1, 2 and 4 are closest to the pH value of the human vagina. It can be seen from the experimental results that the lower the pH value of the chitosan gynecological gel, the stronger the antibacterial ability, and the chitosan gynecological gel of Example 1 has the best antibacterial ability.

[0043] In the experiment of irritation test, too high amount of chitosan will lead to increased irritation. Example 1, Example 2, Example 4, and Comparative Example 3 are non-irritating, and considering the pH comprehensively, the solution of Example 1 is the best.

[0044] From the antibacterial test results, after 5 minutes of testing, the antibacterial effects of Examples 1-5 and Comparative Examples 1-4 were all good, which may be because the chitosan concentrations of all formulations were greater than the minimum inhibitory concentration of chitosan, and lactic acid and Chinese medicine extracts could also enhance the antibacterial ability to a certain extent.

[0045] In comparative example 3, brown algae oligosaccharide is used instead of chitosan. Brown algae oligosaccharide is a product obtained by treating chitosan with a special bio-enzyme technology. Compared with chitosan, brown algae oligosaccharide also has a certain antibacterial effect, but its raw material cost is high. Therefore, the chitosan gynecological gel of the present invention has a better cost performance than comparative example 3.

[0046] From the comparison results of Comparative Example 4 and Example 1, it can be seen that using citric acid instead of lactic acid can also achieve a certain antibacterial effect, but lactic acid is milder and non-irritating than citric acid for private care.

[0047] The chitosan gynecological gel of the invention has good antibacterial and anti-inflammatory effects and has significant clinical application effects.

[0048] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.

Claims

1. A chitosan gynecological gel, It is characterized in that The raw materials for preparing the chitosan gynecological gel include, by weight percentage, 0.5-2% chitosan, 10-30% glycerol, 0.1-1% sodium hyaluronate, 0.01-0.5% disodium ethylenediaminetetraacetic acid, 1-2.5% hydroxyethyl cellulose, 0.5-1.5% lactic acid, 0.001-0.1% cnidium monnieri extract, 0.001-0.1% scutellaria baicalensis extract, 0.001-0.1% sophora flavescens extract, 0.001-0.1% stemon extract, 0.01-0.1% leonurus extract, and the rest is water.

2. The chitosan gynecological gel according to claim 1, It is characterized in that Calculated by weight percentage, the raw materials for preparing the chitosan gynecological gel also include: 0.1-0.3% of β-glucan.

3. The chitosan gynecological gel according to claim 1 or 2, It is characterized in that Calculated by weight percentage, the raw materials for preparing the chitosan gynecological gel also include: 0.01-0.1% isomaltooligosaccharide.

4. The chitosan gynecological gel according to any one of claims 1 to 3, It is characterized in that The raw materials for preparing the chitosan gynecological gel include, by weight percentage, 1-1.5% chitosan, 0.1-0.2% beta-glucan, 0.03-0.08% isomaltooligosaccharide, 15-25% glycerol, 0.15-0.25% sodium hyaluronate, 0.05-0.15% disodium ethylenediaminetetraacetic acid, 1.5-2% hydroxyethyl cellulose, 0.8-1.2% lactic acid, 0.005-0.015% cnidium monnieri extract, 0.005-0.015% scutellaria baicalensis extract, 0.005-0.015% sophora flavescens extract, 0.005-0.015% stemon extract, 0.03-0.08% leonurus extract, and the rest is water.

5. The chitosan gynecological gel according to claim 4, It is characterized in that The raw materials for preparing the chitosan gynecological gel include, by weight percentage, 1.1% chitosan, 0.1% beta-glucan, 0.05% isomaltooligosaccharide, 20% glycerol, 0.2% sodium hyaluronate, 0.1% disodium ethylenediaminetetraacetic acid, 1.6% hydroxyethyl cellulose, 1% lactic acid, 0.01% cnidium monnieri extract, 0.01% scutellaria baicalensis extract, 0.01% sophora flavescens extract, 0.01% stemon extract, 0.05% leonurus herb extract, and the rest is water.

6. The chitosan gynecological gel according to claim 1, It is characterized in that The purity of the lactic acid is ≥90%.

7. The chitosan gynecological gel according to claim 1, It is characterized in that The viscosity of the hydroxyethyl cellulose in a 1% aqueous solution at 20° C. is 3400-5000 cps.

8. The chitosan gynecological gel according to claim 1, It is characterized in that The pH value of the chitosan gynecological gel is 3.5-4.5, preferably 3.8-4.1, and more preferably 3.85-3.

95.

9. The method for preparing the chitosan gynecological gel according to any one of claims 1 to 8, It is characterized in that The steps include: Step 1: Add chitosan, glycerol, sodium hyaluronate, and disodium edetate into water, and stir to mix and dissolve at room temperature; preferably, add chitosan, β-glucan, isomaltooligosaccharide, glycerol, sodium hyaluronate, and disodium edetate into water, and stir to mix and dissolve at room temperature; Step 2: Under stirring, add hydroxyethyl cellulose to the mixed solution of step 1 and stir to make the hydroxyethyl cellulose swell into a gel, and then cool to below 37°C; Step 3: Add lactic acid, Cnidium monnieri extract, Scutellaria baicalensis extract, Sophora flavescens extract, Stemona japonica extract and Leonurus japonicus extract in sequence at room temperature, stir evenly, and adjust the pH value of the product to acidic.

10. The preparation method according to claim 9, It is characterized in that In step 2, the stirring is magnetic stirring at 75-85° C. for 20-40 min.

Citation Information

Cited By

  • Gel for repairing endometrial injury and preparation method thereof

    CN119792192A

  • Antibacterial gel for female private part nursing and preparation method thereof

    CN120815132A

  • A bacteriostatic gel for female intimate care and a method for preparing the same

    CN120815132B